News

Filter

Current filters:

None

7913 to 7922 of 97916 results

Ipsen's hemophilia partner Inspiration Biopharma seeks Chapter 11 protection

01-11-2012

French drugmaker Ipsen (Euronext: IPN) announced yesterday that its partner, privately-held US firm Inspiration…

FinancialInspiration BiopharmaceuticalsIpsenPharmaceutical

Catalyst Pharma partners with BioMarin for Firdapse in North America

31-10-2012

Catalyst Pharmaceutical Partners (Nasdaq: CPRX) and fellow USA-based BioMarin Pharmaceutical (Nasdaq:…

BioMarin PharmaceuticalCatalyst PharmaceuticalFirdapseLicensingNorth AmericaPharmaceuticalRare diseases

New study highlights enabling factors for biopharmaceutical innovation in middle-income countries

31-10-2012

While pharmaceutical R&D is still heavily concentrated in high-income countries, there is a trend of…

BiotechnologyGlobalPharmaceuticalResearch

Charles River Labs to buy majority stake in China's Vital River

31-10-2012

USA-based Charles River Laboratories International (NYSE:CRL) has entered into an agreement to acquire…

Asia-PacificCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalVital River

Hyperparathyroidism therapeutics market to reach $2.62 billion by 2019

31-10-2012

Hyperparathyroidism (HPT) patients can expect a slow but steady change in treatment options, as pharmaceutical…

Markets & MarketingMetabolicsPharmaceuticalResearch

Drugmakers spend an average $237,000 per medical science liaison in the USA

31-10-2012

US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

Novo Nordisk net profit leaps 26% in first nine months of 2012

31-10-2012

Danish insulin giant Novo Nordisk (NOV: N) today reported financial results for the first nine months…

DiabetesFinancialNovo NordiskPharmaceutical

7913 to 7922 of 97916 results

Back to top